GELS
Gelteq Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · AU
$0.56
−3.07%Margins
Gross margin
100.0%
EBITDA margin
-2129.8%
EBIT margin
-3317.7%
Net margin
-4011.9%
FCF margin
-3721.1%
-46.8%
Return on equity
-33.0%
Return on assets
-28.5%
Return on invested capital
—
Asset turnover
-$3.9M
Cash from operations
$0.00
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025